[
  {
    "ts": "2025-01-13T14:54:00+00:00",
    "headline": "RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test",
    "summary": "Revvity aims to expand the FDA-cleared menu for the EUROIMMUN family of ChLIA automation solutions to serve a wider patient pool.",
    "url": "https://finance.yahoo.com/news/rvty-stock-falls-despite-fda-145400141.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "04088f57-193a-39b1-9107-08908e3b16ec",
      "content": {
        "id": "04088f57-193a-39b1-9107-08908e3b16ec",
        "contentType": "STORY",
        "title": "RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test",
        "description": "",
        "summary": "Revvity aims to expand the FDA-cleared menu for the EUROIMMUN family of ChLIA automation solutions to serve a wider patient pool.",
        "pubDate": "2025-01-13T14:54:00Z",
        "displayTime": "2025-01-13T14:54:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w5T7o1LHfvUowVKdWOi4Rg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3L0ANckA9Qf5lXTiNAgdWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/rvty-stock-falls-despite-fda-145400141.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rvty-stock-falls-despite-fda-145400141.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVTY"
            },
            {
              "symbol": "RMD"
            },
            {
              "symbol": "CAH"
            },
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-01-13T13:00:00+00:00",
    "headline": "Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing",
    "summary": "WALTHAM, Mass. & SAN DIEGO, January 13, 2025--Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic sequencing solutions. This initiative builds upon Revvity's recent introduction of an automated next-generation sequencing (NGS) workflow for newborn sequencing research and stren",
    "url": "https://finance.yahoo.com/news/revvity-element-biosciences-collaborate-advance-130000040.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "4b804e31-8ff9-3478-b8b7-b530d3af9b03",
      "content": {
        "id": "4b804e31-8ff9-3478-b8b7-b530d3af9b03",
        "contentType": "STORY",
        "title": "Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing",
        "description": "",
        "summary": "WALTHAM, Mass. & SAN DIEGO, January 13, 2025--Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic sequencing solutions. This initiative builds upon Revvity's recent introduction of an automated next-generation sequencing (NGS) workflow for newborn sequencing research and stren",
        "pubDate": "2025-01-13T13:00:00Z",
        "displayTime": "2025-01-13T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/4b135df3b22403b9a3d37f080bce70e2",
          "originalWidth": 784,
          "originalHeight": 320,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dKuK4TlZsIOpQCf1av9ItA--~B/aD0zMjA7dz03ODQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/4b135df3b22403b9a3d37f080bce70e2.cf.webp",
              "width": 784,
              "height": 320,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B49Uk5Ojqpf4setDtuVMHg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/4b135df3b22403b9a3d37f080bce70e2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/revvity-element-biosciences-collaborate-advance-130000040.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/revvity-element-biosciences-collaborate-advance-130000040.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVTY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]